{"transactions":[{"id":934147,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":69055,"kind":"person","name":"Frelick Jeff","position":1,"cik":"0001645093","reported_name":"Frelick Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option","published_at":"2026-01-21T21:37:13.000Z","date":"2026-01-08","kind":"grant","planned":false,"acquired":true,"shares":16668,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests and becomes exercisable immediately."}],"balance_after":16668,"derivative":{"exercise_price":1.55,"exercise_date":"2026-01-08","expiration_date":"2036-01-08","underlying":"Common Stock","underlying_shares":16668},"source":{"system":"sec-edgar","filing":"0001493152-26-003102","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315226003102/ownership.xml","form_type":"4"}},{"id":1298704,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":69055,"kind":"person","name":"Frelick Jeff","position":1,"cik":"0001645093","reported_name":"Frelick Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option","published_at":"2025-01-21T11:10:12.000Z","date":"2025-01-15","kind":"grant","planned":false,"acquired":true,"shares":54110,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice,vests and becomes exercisable immediately."}],"balance_after":54110,"derivative":{"exercise_price":0.9678,"exercise_date":"2025-01-15","expiration_date":"2027-01-15","underlying":"Common Stock","underlying_shares":54110},"source":{"system":"sec-edgar","filing":"0001493152-25-002884","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315225002884/ownership.xml","form_type":"4"}},{"id":1675114,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":69055,"kind":"person","name":"Frelick Jeff","position":1,"cik":"0001645093","reported_name":"Frelick Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option","published_at":"2024-01-19T22:22:54.000Z","date":"2024-01-17","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests and becomes exercisable immediately."}],"balance_after":25000,"derivative":{"exercise_price":3.61,"exercise_date":"2024-01-17","expiration_date":"2026-01-17","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-24-003097","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315224003097/ownership.xml","form_type":"4"}},{"id":1782855,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":69055,"kind":"person","name":"Frelick Jeff","position":1,"cik":"0001645093","reported_name":"Frelick Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-09-12T15:34:57.000Z","date":"2023-09-11","kind":"purchase","planned":false,"acquired":true,"shares":9500,"price":0.6874,"value":6530.3,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6799 to $0.6898, inclusive. Mr. Frelick undertakes to provide Bone Biologics Corporation, any security holder of Bone Biologics Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":17204,"source":{"system":"sec-edgar","filing":"0001493152-23-032321","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315223032321/ownership.xml","form_type":"4"}},{"id":1789055,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":69055,"kind":"person","name":"Frelick Jeff","position":1,"cik":"0001645093","reported_name":"Frelick Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-09-05T21:05:23.000Z","date":"2023-08-31","kind":"purchase","planned":false,"acquired":true,"shares":7600,"price":0.6605,"value":5019.8,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 104 shares of vested restricted stock that were inadvertently reported in Table II at the time of grant."}],"balance_after":7704,"source":{"system":"sec-edgar","filing":"0001493152-23-031680","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315223031680/ownership.xml","form_type":"4"}},{"id":1963100,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":69055,"kind":"person","name":"Frelick Jeff","position":1,"cik":"0001645093","reported_name":"Frelick Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option","published_at":"2023-03-08T11:20:27.000Z","date":"2023-01-25","kind":"grant","acquired":true,"shares":37750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":140140,"derivative":{"exercise_price":0.24,"exercise_date":"2023-01-25","expiration_date":"2025-01-25","underlying":"Common Stock","underlying_shares":37750},"source":{"system":"sec-edgar","filing":"0001493152-23-006968","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315223006968/ownership.xml","form_type":"4"}},{"id":2368770,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":69055,"kind":"person","name":"Frelick Jeff","position":1,"cik":"0001645093","reported_name":"Frelick Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option","published_at":"2022-02-28T11:05:13.000Z","date":"2022-01-01","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":102389,"derivative":{"exercise_price":3.72,"exercise_date":"2022-01-01","expiration_date":"2025-01-01","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-22-005548","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315222005548/ownership.xml","form_type":"4"}},{"id":3984962,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":69055,"kind":"person","name":"Frelick Jeff","position":1,"cik":"0001645093","reported_name":"Frelick Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Unit","published_at":"2018-03-22T10:05:24.000Z","date":"2018-02-16","kind":"grant","acquired":true,"shares":60914,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 16, 2018, the Reporting Person was granted 60,914 shares of restricted stock units which will become fully vested 2 years from the grant date on February 16, 2020, provided the Reporting Person is still providing services to the issuer on the respective date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On February 16, 2018, the Reporting Person was granted 60,914 shares of restricted stock units which will become fully vested 2 years from the grant date on February 16, 2020, provided the Reporting Person is still providing services to the issuer on the respective date."}],"balance_after":77377,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":60914},"source":{"system":"sec-edgar","filing":"0001493152-18-003733","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315218003733/form4.xml","form_type":"4"}},{"id":4347420,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":69055,"kind":"person","name":"Frelick Jeff","position":1,"cik":"0001645093","reported_name":"Frelick Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-04-21T20:42:54.000Z","date":"2016-05-27","kind":"grant","acquired":true,"shares":269145,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On May 27, 2016, the Reporting Person was granted 269,145 stock options, 1/3 of the shares subject to the option vest on each anniversary of the Vesting Commencement Date, subject to the option holder's Continuous Service (as defined in the Plan) on each vesting date, provided the Reporting Person is still providing services to the Issuer on the respective date."}],"balance_after":1326204,"derivative":{"exercise_price":2.05,"expiration_date":"2026-05-26","underlying":"Common Stock","underlying_shares":269145},"source":{"system":"sec-edgar","filing":"0001493152-17-004280","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315217004280/form4.xml","form_type":"4"}}]}